cycle dude, I think we are still talking about animal studies in your posted link. Duke said they wanted to begin human studies ASAP. I can think of Panzem as an HIF inhibitor drug that has passed phase I, human safety studies. Might there be more? Don't know.
I hope Duke understands that radiation is antiangiogenic, too. That means give the Panzem to the patient first to get a loading dose, IMO.
"The Duke scientists hope to test this potential new therapy plus radiation in humans within the very near future. Results of their current findings are reported in the May, 2004, issue of Cancer Cell."
News 
Market Data 
Discover 
AI
